Abstract |
We report the case of a patient with a non-Hodgkin lymphoma, who after a standard chemotherapy protocol, developed retroperitoneal fibrosis (RPF) in the absence of radiotherapy or other known causes. The final diagnosis was reached with the microscopic examination of tissue obtained by fine-needle aspiration and true-cut biopsy of the retroperitoneal mass. RPF can be related to chemotherapy alone.
|
Authors | Ambrogio Fassina, Rafael Boscolo Berto, Rafi El Mazloum, Fedra Gottardo, Walter Artibani |
Journal | European urology
(Eur Urol)
Vol. 51
Issue 1
Pg. 270-1; quiz 272
(Jan 2007)
ISSN: 0302-2838 [Print] Switzerland |
PMID | 16632190
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Cytarabine
- Bleomycin
- Vincristine
- Etoposide
- Doxorubicin
- Cyclophosphamide
- Prednisone
- Methotrexate
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects)
- Bleomycin
(adverse effects)
- Cyclophosphamide
(adverse effects)
- Cytarabine
(adverse effects)
- Doxorubicin
(adverse effects)
- Etoposide
(adverse effects)
- Female
- Humans
- Lymphoma, Non-Hodgkin
(drug therapy)
- Methotrexate
(adverse effects)
- Prednisone
(adverse effects)
- Retroperitoneal Fibrosis
(chemically induced)
- Retroperitoneal Neoplasms
(drug therapy)
- Vincristine
(adverse effects)
|